US Stock MarketDetailed Quotes

GALT Galectin Therapeutics

Watchlist
  • 1.150
  • +0.280+32.17%
Close Dec 27 16:00 ET
  • 1.120
  • -0.030-2.61%
Post 19:57 ET
72.18MMarket Cap-1.58P/E (TTM)

About Galectin Therapeutics Company

Galectin Therapeutics, Inc. is a biotechnology company, which engages in drug research and development to create new therapies for fibrotic disease, severe skin disease, and cancer. Its programs target the development of carbohydrate molecules which offers alternative options to larger market segments. The company was founded by James C. Czirr and Anatole A. Klyosov on July 10, 2000 and is headquartered in Norcross, GA.

Company Profile

SymbolGALT
Company NameGalectin Therapeutics
Listing DateSep 10, 2003
Founded2000
CEOMr. Joel Lewis
MarketNASDAQ
Employees14
Fiscal Year Ends12-31
Address4960 Peachtree Industrial Boulevard,Suite 240
CityNorcross
ProvinceGeorgia
CountryUnited States of America
Zip Code30071
Phone1-678-620-3186
Websitehttp://www.galectintherapeutics.com

Company Executives

  • Name
  • Position
  • Salary
  • Joel Lewis
  • Director, President and Chief Executive Officer
  • 963.65K
  • Dr. Khurram Jamil
  • Chief Medical Officer
  • --
  • Jack W. Callicutt
  • Chief Financial Officer and Principal Accounting Officer
  • 561.42K
  • Richard E. Uihlein
  • Chairman of the Board
  • 71.74K
  • Dr. Benjamin S. Carson,Sr,M.D.
  • Director
  • 2.72K
  • Dr. Harold H. Shlevin,PhD
  • Independent Director
  • 71.74K
  • Dr. Elissa J. Schwartz, PhD
  • Independent Director
  • 75.24K
  • Kevin D. Freeman
  • Independent Director
  • 87.74K
  • Dr. Marc Rubin,M.D.
  • Independent Director
  • 75.24K
  • Dr. Gilbert S. Omenn,M.D.,PhD
  • Independent Director
  • 81.74K
  • Dr. Gilbert F. Amelio,PhD
  • Independent Director
  • 87.24K
  • Richard A. Zordani
  • Independent Director
  • 86.74K
  • Kary Eldred
  • Independent Director
  • 79.24K
Heat List
US
Overall
Symbol
Price
% Chg

No Data

Investment Theme Top Gainers Yesterday
Top Gainers Yesterday
Intraday-4.68%